Skip to main content
SpringerLink
Log in

Nocturnal blood pressure changes in Parkinson’s disease: correlation with autonomic dysfunction and vitamin D levels

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Nocturnal blood pressure (BP) changes are an indicator of autonomic dysfunction. We aim to investigate the correlation between nocturnal blood pressure (BP) variability, vitamin D levels and Parkinson’s disease severity (PD) in this study. Thirty-five patients with PD participated in the study. Disease severity was evaluated by United Parkinson’s Disease Rating Scale (UPDRS) and Hoehn and Yahr Scale (HYS). Equivalent levodopa dose was calculated and 25-hydroxyvitamin D levels were measured. The Non-Motor Symptom Questionnaire (NMSQ) was applied to all patients. Ambulatory BP monitoring for 24 h was established. Patients were divided into three groups according to nocturnal BP results: dippers (normal finding—a decline in mean nighttime BP of more than 10%); non-dippers (pathological—a decline in mean nighttime BP of less than 10%); reverse dippers (pathological—an increase in mean nighttime BP) .The mean score of the NMSQ was higher in the group with HYS > 2 (p = 0.050). Four patients were dipper, 17 patients were non-dipper and 16 patients were reverse dipper. There was no significant difference between the three groups in terms of age, gender, disease duration, age of the disease onset, disease stage, disease duration, dopamine agonist usage, levodopa equivalent dose, vitamin D level and NMSQ scores. NMSQ scores are high in advanced PD. Ambulatory BP monitoring is useful in detecting autonomic dysfunction. The number of patients with non-dipping and reverse dipping is high in PD, independent from PD severity, drug dose, vitamin D and the other NMS symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Antonini A, Barone P, Marconi R, Morgante L, Zapulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C (2012) The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of lif. J Neurol 259:2621–2631

    PubMed  Google Scholar 

  2. Ha AD, Brown CH, York MK, Jankovic J (2011) The prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism. Parkinsonism Relat Disord 17(8):625–628. https://doi.org/10.1016/j.parkreldis.2011.05.02

    Article  PubMed  Google Scholar 

  3. O’Brien E, Sheridan J, Malley OK (1998) Dippers and non-dippers. Lancet 12:397

    Google Scholar 

  4. Di Daniele N, Fegatelli DA, Rovella V, Castagnola V, Gabriele M, Scuteri A (2017) Circadian blood pressure patterns and blood pressure control in patients with chronic kidney disease. Atherosclerosis 267:139–145

    PubMed  Google Scholar 

  5. Ejaz AA, Sekhon IS, Munjal S (2006) Characteristics findings ies of patients with Parkinson’s disease. Er J Intern Med 17:417–420

    Google Scholar 

  6. Schmidt C, Berg D, Prieur S. Et al. Schmidt C, Berg D, Herting, Prieur S, Junghanns S, Schweitzer K, Globas C, Schöls L, Reichmann H, Ziemssen T (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24:2136–2142

    PubMed  Google Scholar 

  7. Senard JM, Chamontin B, Rascol A, Montastruc JL (1992) Neurogenic orthostatic hypotension as the initial feature of Parkinson disease. Clin Auton Res 2:99–104

    CAS  PubMed  Google Scholar 

  8. Linden D, Diehl RR, Berlit P (1997) Sympathetic cardiovascular dysfunction in longstanding idiopathic Parkinson’s disease. Clin Auton Res 7:311–314

    CAS  PubMed  Google Scholar 

  9. Goldstein DS (2006) Orthostatic hypotension as an early finding in Parkinson disease. Clin Auton Res 16:46–54

    PubMed  Google Scholar 

  10. Milazzo V, Di Stefano C, Servo S, Zibetti M, Lopiano L, Maule S (2012) Neurogenic orthostatic hypotension as the initial feature of Parkinson disease. Clin Auton Res 22:203–206

    PubMed  Google Scholar 

  11. Kalueff AV, Eremin KO, Tuohımaa P (2004) Mechanisms of neuropretective action of vitamin D3. Biochemistry 69:738–741

    CAS  PubMed  Google Scholar 

  12. Jang W, Park J, Kim JS, Youn J, Oh E, Kwon KY, Jo KD, Lee MK, Kim H-T (2015) Vitamin D deficiency in Parkinson’s disease patients with orthostatic hypotension. Acta Neurol Scand 132:242–250

    CAS  PubMed  Google Scholar 

  13. Pilz S, Tomaschitz A, Ritz E, Pieber TR (2009) Vitamin D status and arteriel hypertension: a systematic review. Nat rev Cardiol 6:621–630

    CAS  PubMed  Google Scholar 

  14. Vinh Quoc Luong K, Thi Hoang Nguyen L (2012) Vitamin D and Parkinson’s disease. J Neurosci Res 90:2227–2236

    PubMed  Google Scholar 

  15. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson’s. Disease Mov Disord 25:2649–2653

    PubMed  Google Scholar 

  17. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D (2000) Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987–1996. Stroke 31:2307–2313

    CAS  PubMed  Google Scholar 

  18. Schapira AH (2013) Recent developments in biomarkers in Parkinson disease. Curr Opin Neurol 26:395–400

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson’s disease: diagnosis andmanagement. Lancet Neurol 5:235–245

    PubMed  Google Scholar 

  20. Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, PRIAMO study group (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649

    PubMed  Google Scholar 

  21. Crosiers D, Pickut B, Theuns J, Deyn PP, Van Broeckhoven C, Martinez-Martin P, Chaudhuri KR, Cras P (2012) Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson’s disease patients as assessed by the Non-motor Symptoms Questionnaire. Am J Neurodegener Dis 1:160–167

    PubMed  PubMed Central  Google Scholar 

  22. Gan J, Zhou M, Chen W, Liu Z (2014) Non-motor symptoms in Parkinson’s disease patients. J Clin Neurosci 21:751–754

    PubMed  Google Scholar 

  23. Hermida RC (2007) Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol Int 24:749–775

    PubMed  Google Scholar 

  24. Saladini F, Di Marco A, Palatini P (2016) Autonomic dysfunction: how to identify and when to treat? High Blood Press Cardiovasc Prev 23:237–243

    PubMed  Google Scholar 

  25. Park JH, Lee HS, Kim JH, Lee JH, Kim J, Choi SW (2014) J Stroke Cerebrovasc Dis 23:1171–1176

    PubMed  Google Scholar 

  26. Yan B, Peng L, Dong Q, Zheng F, Yang P, Sun L, Gong S, Zeng L, Wang G (2015) Reverse-dipper pattern of blood pressure may predict lacunar infarction in patients with essential hypertension. Reverse-dipper pattern of blood pressure may predict lacunar infarction in patients with essential hypertension. Eur J Neurol 22:1022–1025

    CAS  PubMed  Google Scholar 

  27. Wang C, Ye Z, Li Y, Zhang J, Zhang Q, Ma X, Peng H, Lou T (2016) Prognostic value of reverse dipper blood pressure pattern in chronic kidney disease patients not undergoing dialysis: prospective cohort study. Sci Rep 6:34932

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Sommer S, Aral-Becher B, Jost W (2011) Nondipping in Parkinson’s disease. Parkinsons Dis 2011:897586

    PubMed  PubMed Central  Google Scholar 

  29. Oh YS, Kim JS, Chung YA, You IeR, Yang DW, Chung SW, Park JW, Kim YI, Lee KS (2013) Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease. Neurol Sci 34:557–560

    PubMed  Google Scholar 

  30. Milazzo V, Di Stefano C, Vallelonga F, Sobrero G, Zibetti M, Romagnolo A, Merola A, Milan A, Espay AJ, Lopiano L, Veglio F, Maule S (2018) Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Parkinsonism Relat Disord

  31. Noack C, Schroeder C, Heusser K, Lipp A (2014) Cardiovascular effects of levodopa in Parkinson’s disease. Parkinsonism Relat Disord 20:815–818

    PubMed  Google Scholar 

  32. Mehagnoul-Schipper DJ, Boerman RH, Hoefnagels WH, Jansen RW (2001) Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients. J Gerontol A Biol Sci Med Sci 56:M749–M755

    CAS  PubMed  Google Scholar 

  33. Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, Sharabi Y (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333–1339

    CAS  PubMed  Google Scholar 

  34. Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG (2000) Acute orthostatic hypotension when starting dopamine agonists in Parkinson’s disease. Arch Neurol 57:1461–1463

    CAS  PubMed  Google Scholar 

  35. Sánchez-Ferro A, Benito-León J, Gómez-Esteban JC (2013) The management of orthostatic hypotension in Parkinson’s disease. Front Neurol 4:64

    PubMed  PubMed Central  Google Scholar 

  36. Resta O, Rana L, Procacci V, Guido P, Picca V, Scarpelli F (1998) Autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome. Monaldi Arch Chest Dis 53(1):23–29

    CAS  PubMed  Google Scholar 

  37. Cortelli P, Parchi P, Sforza E, Contin M, Pierangeli G, Barletta G, Lugaresi E (1994) Cardiovascular autonomic dysfunction in normotensive awake subjectswith obstructive sleep apnoea syndrome. Clin Auton Res 4(1–2):57–62

    CAS  PubMed  Google Scholar 

  38. Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46:572–580

    CAS  PubMed  Google Scholar 

  39. Jang W, Park HH, Lee KY, Lee YJ, Kim HT, Koh SH (2015) 1,25-dyhydroxyvitamin D3 attenuates L-DOPA-induced neurotoxicity in neural stem cells. Mol Neurobiol 51:558–570

    CAS  PubMed  Google Scholar 

  40. Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V (2011) High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol 68:314–319

    PubMed  Google Scholar 

  41. Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR (2013) Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology 81:1531–1537

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Newmark HL, Newmark J (2007) Vitamin D and Parkinson’s disease-a hypothesis. Mov Disord 22:461–468

    PubMed  Google Scholar 

  43. Petersen MS, Bech S, Christiansen DH, Schmedes AV, Halling J (2014) The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson’s disease in the Faroe Islands. Neurosci Lett 561:74–79

    CAS  PubMed  Google Scholar 

  44. Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, Urashima M (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97:1004–1013

    CAS  PubMed  Google Scholar 

  45. Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 28:205–221

    CAS  PubMed  Google Scholar 

  46. Pekkanen MP, Ukkola O, Hedberg P, Piira OP, Lepojärvi S, Lumme J, Tulppo MP, Huikuri HV (2015) Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 25:471–478

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Faculty of Medicine, Istanbul Medipol University, TEM Avrupa Otoyolu Göztepe Çıkışı, No:1 Bağcılar, 34214, Istanbul, Turkey

    Ozge Arici Duz & Nesrin Helvaci Yilmaz

Authors
  1. Ozge Arici Duz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nesrin Helvaci Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozge Arici Duz.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arici Duz, O., Helvaci Yilmaz, N. Nocturnal blood pressure changes in Parkinson’s disease: correlation with autonomic dysfunction and vitamin D levels. Acta Neurol Belg 120, 915–920 (2020). https://doi.org/10.1007/s13760-019-01113-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01113-7

Keywords

Search

Navigation